Construction of pUC118-based vectors expressing mutant 56-8 (pLE56-8), WT hAGT (pFC6) and inactive hAGT (pFC9) has been described previously decreased Ͼ2.5-fold in cells expressing the mutant hAGT, (17,19). pFC9 contains a 1.7 kb stuffer fragment that replaces a 141 base whereas WT hAGT totally prevented G:C→A:T mutations. 
Introduction
carbon source; however, the E.coli can be reverted to Lac ϩ via either A:T→G:C (CJM1) or G:C→A:T (CJM2) transition mutations. Cells were Alkylating agents react extensively with DNA to produce a grown in either 2ϫ YT or M9 minimal medium containing the appropriate multitude of different adducts (1) . This diversity makes it antibiotics and 50 µM isopropyl-β-D-galactopyranoside (IPTG). Minimal difficult to determine the biological significance of individual plates contained either 0.025% glucose or lactose, 0.025% thiamine, 40 µg/ml lesions. In vitro and in vivo studies using site-specific DNA methionine, 1 mM MgSO 4 , 0.1 mM CaCl 2 and antibiotics (carbenicillin, kanamycin, chloramphenicol and tetracycline) as described previously (23) .
adducts suggest that certain adducts, e.g. 3-methyladenine can block polymerases during replication (2,3), whereas other
MNNG-induced mutagenicity assay
lesions, e.g. O 6 -methylguanine (m 6 G) and O 4 -methylthymine CJM1 or CJM2 cells, transformed with either pLE56-8 (hAGT mutant 56-8), pFC6 (WT hAGT), pFC9 (inactive hAGT) or pUCogt (E.coli Ogt) were (m 4 T), allow bypass, and miscode during polymerization to grown in 2ϫ YT medium containing the appropriate antibiotics and IPTG to produce mutations (4-6). m 4 T is formed less frequently than OD 600 ϭ 0.8. Ten milliliter aliquots (10 10 cells) were washed and resuspended m 6 G by alkylating agents; however, it is a more potent source in 10 ml of M9 salts, treated with varying concentrations of MNNG for of mutations when examined in both prokaryotic and eukaryotic 30 min at 37°C, and washed again with M9 salts. In experiments including BG, the inhibitor was present at a concentration of 100 µM both prior to and cells (7-12). Both adducts are repaired in human cells by during exposure to MNNG as described previously (17). Appropriate dilutions O 6 -alkylguanine-DNA alkyltransferase (hAGT, EC 2.1.1.63), of the cells were spread on minimal plates containing either glucose (for a protein that transfers alkyl groups from DNA to a cysteine estimating survival) or lactose (for estimating the number of lacZ revertants).
residue within the active site (13, 14) . hAGT is a suicide protein Following incubation at 37°C for 48 h, colonies were counted and mutagenicity because each protein carries out a single reaction before being products were purified and then sequenced using PE Biosytems (Foster City, CA) Big dye terminator chemistry. The primer used for sequencing was the forward PCR primer mentioned above.
Results

hAGT mutant 56-8 repairs m 4 T and m 6 G in vivo
We have shown previously that the hAGT mutant 56-8 repairs m 4 T more effectively than the WT protein in vitro (18). In order to determine if this altered specificity is exhibited in vivo, we measured cell survival and mutations produced by unrepaired m 4 T and m 6 G in cells expressing the mutant and WT hAGTs. We made use of a series of reporter strains established by J.Miller to detect the induction of specific types of mutations. These strains are also deficient in nucleotide excision repair (uvr), a pathway that could contribute to the repair of m 4 T and m 6 G (10, 21, 24) . Plasmids encoding alkyltransferases were introduced into alkyltransferase-deficient E.coli strains CJM1 and CJM2. In vivo repair was measured by the mutant's ability to prevent A:T→G:C mutations (induced by m 4 T) and G:C→A:T mutations (induced by m 6 G) in CJM1 and CJM2 cells, respectively. The reporter strains each contain specific nucleotide substitutions in their episomal lacZ gene, rendering the cells unable to grow on lactose. The lacZ mutations can revert from Lac -to Lac ϩ by specific point mutations that are induced by either m 4 T (CJM1) or m 6 G (CJM2). Mutations are scored by colony formation on plates containing minimal medium and lactose as a sole source of carbon. We compared the efficiency of DNA repair of m 4 T and m 6 G in vivo by three DNA alkyltransferases: mutant 56-8 hAGT, WT hAGT and the bacterial alkyltransferase, Ogt. Ogt was used as a positive control because it repairs both To verify the nature of the Lac ϩ phenotype acquired by the as a function of increasing amounts of MNNG. Mutations at mutant clones following exposure to MNNG, we sequenced a the highest dose of MNNG (1 µg/ml) were reduced by 10% region of the F' episomal DNA surrounding codon 461 of the in cells transformed with WT hAGT. In contrast, mutagenesis lacZ gene from untreated Lac -and MNNG-induced Lac ϩ cells at this dose was reduced 76% in cells expressing mutant 56-harboring either mutant 56-8 or WT hAGT. With each strain, 8 hAGT. Cells expressing Ogt failed to produce detectable five Lac -and 15 Lac ϩ colonies were used to prepare episomal A:T→G:C mutations at these doses of MNNG. This is in DNA for sequencing. Table I summarizes these results. For accord with the known ability of Ogt to repair m 4 T in vivo every revertant examined, the predicted mutation had occurred very effectively (21) .
to restore the WT GAG codon at position 461. Because MNNG induces more m 6 G than m 4 T, lower doses of
The substrate specificity of mutant 56-8 hAGT is unaltered methylating agent are required to produce detectable G:C→A:T by BG mutations in m 6 G reporter cells (CJM2). MNNG was not lethal to CJM2 cells expressing any of the active alkyltransferases It has been shown previously that the hAGT inhibitor, BG can render bacteria harboring WT hAGT sensitive to cytotoxicity tested (56-8, WT or Ogt), and only marginally toxic to cells expressing inactive protein (Figure 2A) . Results of mutagenesis induced by MNNG (25) . In contrast, cells expressing mutant 56-8 hAGT are resistant (17). To examine the effect of BG in the m 6 G reporter strain are presented in Figure 2B . In cells transfected with the inactive construct there was a linear on mutagenesis, m 4 T or m 6 G reporter cells (CJM1 and CJM2, respectively) harboring either the mutant or WT hAGT were increase in mutations with increasing doses of MNNG. Mutagenesis was reduced 63% in cells expressing the mutant at the treated with increasing concentrations of MNNG in the presence of 100 µM BG. In the case of CJM1 cells harboring the highest dose of MNNG. An even greater reduction was observed in cells harboring the WT hAGT or Ogt constructs, mutant ( Figure 3A) , BG did not reduce cell survival, and survival was similar to that shown in Figures 1 and 2 . In the as no mutations above background were detected with either alkyltransferase. Thus, mutant 56-8 hAGT is more effective case of the cells expressing the WT hAGT, BG increased MNNG-induced killing. At the highest dose of MNNG used in diminishing mutagenesis in the m 4 T reporter strain than in the m 6 G reporter strain. In contrast, WT hAGT prevents (1 µg/ml), the survival of cells harboring WT hAGT was 10-fold greater than cells expressing an inactive protein. In CJM2 cells expressing WT hAGT, with the greatest effect observed at the higher doses of MNNG. The finding that at the presence of BG this protection was reduced to~2-fold. BG had no effect on the onset of A:T→G:C mutations in m 4 T 0.3 µg/ml MNNG, cells harboring WT hAGT accumulated no detectable mutations in the absence of BG suggests that the reporter cells (CJM1) harboring either mutant 56-8 or WT hAGT ( Figure 3B ). Presumably, even though BG inactivates WT protein is able to completely repair the m 6 G lesions induced by MNNG. However, when it was inactivated by BG, WT hAGT, the WT protein is not rate limiting for the repair of m 4 T. these cells develop nearly 5000 mutations per 10 8 surviving cells, which is Ͼ1000 (~33%) more than were observed in In the case of m 6 G reporter cells (CJM2) there was no reduction in survival in bacteria harboring the mutant or WT cells harboring the mutant hAGT. Sensitivity to BG was dependent on an active alkyltransferase; it should be noted hAGT as a function of increasing amounts of MNNG in the presence of BG ( Figure 4A ). However, mutagenesis was a that the inhibitor did not have an effect on the survival or mutagenicity of cells harboring an inactive protein (data more sensitive indicator of DNA damage. BG did have a significant enhancing effect on mutagenesis (G:C→A:T) in not shown). improved ability to prevent A:T→G:C mutations, mutant 56-8 did not protect the bacteria as well as WT hAGT against G:C→A:T mutations, suggesting that the mutant protein is less effective at repairing m 6 G than the WT. Together these findings verify our previous biochemical characterization of the mutant as having a reversed substrate specificity for m 4 T and m 6 G compared with WT hAGT. More importantly these data suggest that in vitro repair by alkyltransferases can be predictive of repair in vivo. Mutant 56-8 hAGT is unusual in that it contains eight amino acid substitutions adjacent to the active site and yet maintains WT-like activity for protecting cells against MNNG-induced cytotoxicity. The number of substitutions within a contiguous sequence in this mutant is greater than any other enzyme so far generated by selection from random sequences. In addition to having an altered substrate specificity for m 4 T, mutant 56-8 also confers resistance to BG in bacteria (17) and in human cells (B.M.Davis, L.P.Encell, S.P.Zielske, F.C.Christians, L.Liu, S.E.Friebert, L.A.Loeb and S.L.Gerson, manuscript in preparation). In contrast, WT hAGT is highly sensitive to inhibition by BG, an inhibitor that is being used in clinical trials for sensitizing tumors to chemotherapeutic alkylating agents whose effectiveness is diminished by repair involving measure mutant 56-8's ability to prevent mutations following exposure to a combination of MNNG and BG. The inhibitor had no effect on the induction of either type of mutation Discussion (A:T→G:C or G:C→A:T) by MNNG in cells harboring mutant 56-8 hAGT, in accord with the high BG resistance observed Although hAGT repairs both m 4 T and m 6 G, it has a preference for m 6 G. This is of interest because evidence suggests both previously for this mutant (17). BG also had no effect on A:T→G:C mutations in cells expressing the WT protein, adducts contribute to mutagenesis by alkylating agents (26) (27) (28) (29) . Although formed less frequently by alkylating agents, indicating that WT hAGT does not participate significantly in the repair of m 4 T. In contrast, BG highly sensitized CJM2 m 4 T is a more persistent adduct (30, 31) . Presumably this is due to inefficient repair. Using random mutagenesis and genetic cells harboring WT hAGT to an accumulation of G:C→A:T mutations, presumably resulting from unrepaired m 6 G. Cells selection we have evolved an alkyltransferase that repairs m 4 T with increased efficiency compared with the WT protein (18).
harboring WT hAGT developed more G:C→A:T mutations (30%) than cells expressing the mutant. Thus, in the presence In vitro biochemical analysis of this mutant indicated it repairs m 4 T Ͼ10-fold more rapidly than the WT protein; the relative of BG, the mutant is more efficient than the WT hAGT at repairing both m 4 T and m 6 G. It should be pointed out that the m 4 T specificity [k(m 4 T)/k(m 6 G)] for the mutant is increased 75-fold. In order to determine the biological effects of this effects of BG on cells harboring WT hAGT were greatest when higher concentrations of MNNG were used. The WT altered specificity we have now further characterized the mutant by examining its repair capacity in vivo.
protein offers some protection against killing at the lower doses of MNNG even in the presence of BG. One explanation Using two strains of E.coli (CJM1 and CJM2) that detect specific mutations resulting from either unrepaired m 4 T or for this is that residual hAGT that is not depleted by BG is ample for the efficient repair of the relatively low levels of m 6 G, mutant 56-8 and WT hAGT were compared for their abilities to reduce mutagenesis following exposure to MNNG. alkylation damage resulting from these concentrations of MNNG. If this is true, it suggests that at the higher doses of We hypothesized that mutant 56-8 hAGT would be more efficacious than WT hAGT at preventing the accumulation of MNNG (in the presence of BG), the residual level of the WT hAGT is inadequate for protecting cells against killing and A:T→G:C transitions based on in vitro data indicating enhanced repair of m 4 T. This was indeed the case, as the that cells harboring mutant 56-8 might have a selective growth advantage compared with cells harboring the WT hAGT. mutant offered the cells Ͼ3.5-fold more protection than WT hAGT using a m 4 T reporter strain. WT hAGT offered very It is difficult to predict what the structural changes are in mutant 56-8 hAGT that produce its altered substrate specificity. little protection against these mutations, in agreement with a previous report by Samson et al. (21) . In contrast to its
It is likely that all eight of the substitutions are not required for the interesting phenotype that has been achieved; however, lesion in inducing secondary cancers. If this is true, than the introduction of mutant 56-8 to the bone marrow of patients it would be difficult to identify the critical substitution(s) among the eight. It should be pointed out that seven of the would offer better protection against the initiation of secondary cancers. eight mutations are at sites where WT hAGT differs from the E.coli alkyltransferase, Ogt. The similarity in the positions mutated between Ogt and mutant 56-8 hAGT is depicted in the
